{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:49:54Z","timestamp":1792601394911,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s40262-025-01575-4","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T02:49:26Z","timestamp":1759718966000},"page":"1869-1883","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Spatial Pharmacokinetic and Pharmacodynamic Modeling in Airway Mucus"],"prefix":"10.1007","volume":"64","author":[{"given":"Yuchen","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirin","family":"Yonucu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherijne A. J.","family":"Knibbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1664-7314","authenticated-orcid":false,"given":"J. G. Coen","family":"van Hasselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"1575_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJMra1813799","volume":"380","author":"RC Boucher","year":"2019","unstructured":"Boucher RC. Muco-obstructive lung diseases. N Engl J Med. 2019;380:1941\u201353. https:\/\/doi.org\/10.1056\/NEJMra1813799.","journal-title":"N Engl J Med"},{"key":"1575_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.addr.2008.09.012","volume":"61","author":"SK Lai","year":"2009","unstructured":"Lai SK, Wang Y-Y, Wirtz D, Hanes J. Micro- and macrorheology of mucus. Adv Drug Deliv Rev. 2009;61:86\u2013100. https:\/\/doi.org\/10.1016\/j.addr.2008.09.012.","journal-title":"Adv Drug Deliv Rev"},{"key":"1575_CR3","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMra0910061","volume":"363","author":"JV Fahy","year":"2010","unstructured":"Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010;363:2233\u201347. https:\/\/doi.org\/10.1056\/NEJMra0910061.","journal-title":"N Engl J Med"},{"key":"1575_CR4","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1042\/BST20170402","volume":"46","author":"C Ridley","year":"2018","unstructured":"Ridley C, Thornton DJ. Mucins: the frontline defence of the lung. Biochem Soc Trans. 2018;46:1099\u2013106. https:\/\/doi.org\/10.1042\/BST20170402.","journal-title":"Biochem Soc Trans"},{"key":"1575_CR5","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1021\/js950381s","volume":"85","author":"PG Bhat","year":"1996","unstructured":"Bhat PG, Flanagan DR, Donovan MD. Drug diffusion through cystic fibrotic mucus: steady-state permeation, rheologic properties, and glycoprotein morphology. J Pharm Sci. 1996;85:624\u201330. https:\/\/doi.org\/10.1021\/js950381s.","journal-title":"J Pharm Sci"},{"key":"1575_CR6","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1128\/AAC.00808-15","volume":"59","author":"JX Huang","year":"2015","unstructured":"Huang JX, Blaskovich MAT, Pelingon R, et al. Mucin binding reduces colistin antimicrobial activity. Antimicrob Agents Chemother. 2015;59:5925\u201331. https:\/\/doi.org\/10.1128\/AAC.00808-15.","journal-title":"Antimicrob Agents Chemother"},{"key":"1575_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jcf.2016.10.001","volume":"16","author":"AC Bos","year":"2017","unstructured":"Bos AC, Pass\u00e9 KM, Mouton JW, et al. The fate of inhaled antibiotics after deposition in cystic fibrosis: how to get drug to the bug? J Cyst Fibros Off J Eur Cyst Fibros Soc. 2017;16:13\u201323. https:\/\/doi.org\/10.1016\/j.jcf.2016.10.001.","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"1575_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1021\/acs.molpharmaceut.1c00644","volume":"19","author":"C Butnarasu","year":"2022","unstructured":"Butnarasu C, Caron G, Pacheco DP, et al. Cystic fibrosis mucus model to design more efficient drug therapies. Mol Pharm. 2022;19:520\u201331. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00644.","journal-title":"Mol Pharm"},{"key":"1575_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0169-409X(01)00115-6","volume":"48","author":"K Khanvilkar","year":"2001","unstructured":"Khanvilkar K, Donovan MD, Flanagan DR. Drug transfer through mucus. Adv Drug Deliv Rev. 2001;48:173\u201393. https:\/\/doi.org\/10.1016\/S0169-409X(01)00115-6.","journal-title":"Adv Drug Deliv Rev"},{"key":"1575_CR10","doi-asserted-by":"publisher","first-page":"E600","DOI":"10.1208\/aapsj070362","volume":"7","author":"M Zeitlinger","year":"2005","unstructured":"Zeitlinger M, M\u00fcller M, Joukhadar C. Lung microdialysis\u2013a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review). AAPS J. 2005;7:E600-608. https:\/\/doi.org\/10.1208\/aapsj070362.","journal-title":"AAPS J"},{"key":"1575_CR11","doi-asserted-by":"publisher","first-page":"1904112","DOI":"10.1002\/smll.201904112","volume":"15","author":"L Yang","year":"2019","unstructured":"Yang L, Gradl R, Dierolf M, et al. Multimodal precision imaging of pulmonary nanoparticle delivery in mice: dynamics of application, spatial distribution, and dosimetry. Small. 2019;15:1904112. https:\/\/doi.org\/10.1002\/smll.201904112.","journal-title":"Small"},{"key":"1575_CR12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/psp4.12344","volume":"7","author":"E Boger","year":"2018","unstructured":"Boger E, Wigstr\u00f6m O. A partial differential equation approach to inhalation physiologically based pharmacokinetic modeling. CPT Pharmacomet Syst Pharmacol. 2018;7:638\u201346. https:\/\/doi.org\/10.1002\/psp4.12344.","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"1575_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008466","volume":"16","author":"N Hartung","year":"2020","unstructured":"Hartung N, Borghardt JM. A mechanistic framework for a priori pharmacokinetic predictions of orally inhaled drugs. PLoS Comput Biol. 2020;16:e1008466. https:\/\/doi.org\/10.1371\/journal.pcbi.1008466.","journal-title":"PLoS Comput Biol"},{"key":"1575_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.bpj.2015.05.034","volume":"109","author":"AM Erickson","year":"2015","unstructured":"Erickson AM, Henry BI, Murray JM, et al. Predicting first traversal times for virions and nanoparticles in mucus with slowed diffusion. Biophys J. 2015;109:164\u201372. https:\/\/doi.org\/10.1016\/j.bpj.2015.05.034.","journal-title":"Biophys J"},{"key":"1575_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100598","volume":"9","author":"SA McKinley","year":"2014","unstructured":"McKinley SA, Chen A, Shi F, et al. Modeling neutralization kinetics of HIV by broadly neutralizing monoclonal antibodies in genital secretions coating the cervicovaginal mucosa. PLoS\u00a0One. 2014;9:e100598. https:\/\/doi.org\/10.1371\/journal.pone.0100598.","journal-title":"PLoS\u00a0One"},{"key":"1575_CR16","doi-asserted-by":"publisher","first-page":"G599","DOI":"10.1152\/ajpgi.00221.2017","volume":"313","author":"OL Lewis","year":"2017","unstructured":"Lewis OL, Keener JP, Fogelson AL. A physics-based model for maintenance of the pH gradient in the gastric mucus layer. Am J Physiol Gastrointest Liver Physiol. 2017;313:G599\u2013612. https:\/\/doi.org\/10.1152\/ajpgi.00221.2017.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1575_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.addr.2008.09.006","volume":"61","author":"Y Cu","year":"2009","unstructured":"Cu Y, Saltzman WM. Mathematical modeling of molecular diffusion through mucus. Adv Drug Deliv Rev. 2009;61:101\u201314. https:\/\/doi.org\/10.1016\/j.addr.2008.09.006.","journal-title":"Adv Drug Deliv Rev"},{"key":"1575_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1021\/ed047p261","volume":"47","author":"JT Edward","year":"1970","unstructured":"Edward JT. Molecular volumes and the stokes-einstein equation. J Chem Educ. 1970;47:261. https:\/\/doi.org\/10.1021\/ed047p261.","journal-title":"J Chem Educ"},{"key":"1575_CR19","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1021\/acsnano.4c14927","volume":"19","author":"O Ponomarchuk","year":"2025","unstructured":"Ponomarchuk O, Boudreault F, Gryczynski I, et al. Nanoscale viscometry reveals an inherent mucus defect in cystic fibrosis. ACS Nano. 2025;19:4637\u201349. https:\/\/doi.org\/10.1021\/acsnano.4c14927.","journal-title":"ACS Nano"},{"key":"1575_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/B978-0-12-812659-2.00009-0","volume-title":"Microfluidics for Pharmaceutical Applications","author":"X-J Ju","year":"2019","unstructured":"Ju X-J, Chu L-Y. Chapter 9 - Lab-on-a-chip fabrication of polymeric microparticles for drug encapsulation and controlled release. In: Santos HA, Liu D, Zhang H, editors. Microfluidics for Pharmaceutical Applications. William Andrew Publishing; 2019. p. 217\u201380."},{"key":"1575_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1556-276X-8-102","volume":"8","author":"A Akbarzadeh","year":"2013","unstructured":"Akbarzadeh A, Rezaei-Sadabady R, Davaran S, et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 2013;8:102. https:\/\/doi.org\/10.1186\/1556-276X-8-102.","journal-title":"Nanoscale Res Lett"},{"key":"1575_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1351\/PAC-REC-10-12-04","volume":"84","author":"M Vert","year":"2012","unstructured":"Vert M, Doi Y, Hellwich K-H, et al. Terminology for biorelated polymers and applications (IUPAC Recommendations 2012). Pure Appl Chem. 2012;84:377\u2013410. https:\/\/doi.org\/10.1351\/PAC-REC-10-12-04.","journal-title":"Pure Appl Chem"},{"key":"1575_CR23","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1172\/JCI73469","volume":"124","author":"AG Henderson","year":"2014","unstructured":"Henderson AG, Ehre C, Button B, et al. Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure. J Clin Invest. 2014;124:3047\u201360. https:\/\/doi.org\/10.1172\/JCI73469.","journal-title":"J Clin Invest"},{"key":"1575_CR24","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1164\/ajrccm.162.5.9909009","volume":"162","author":"NN Sanders","year":"2000","unstructured":"Sanders NN, De Smedt SC, Van Rompaey E, et al. Cystic fibrosis sputum: a barrier to the transport of nanospheres. Am J Respir Crit Care Med. 2000;162:1905\u201311. https:\/\/doi.org\/10.1164\/ajrccm.162.5.9909009.","journal-title":"Am J Respir Crit Care Med"},{"key":"1575_CR25","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1016\/j.bmc.2015.09.021","volume":"23","author":"C Pontremoli","year":"2015","unstructured":"Pontremoli C, Barbero N, Viscardi G, Visentin S. Mucin-drugs interaction: the case of theophylline, prednisolone and cephalexin. Bioorg Med Chem. 2015;23:6581\u20136. https:\/\/doi.org\/10.1016\/j.bmc.2015.09.021.","journal-title":"Bioorg Med Chem"},{"key":"1575_CR26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1248\/bpb.b14-00398","volume":"38","author":"S Gizurarson","year":"2015","unstructured":"Gizurarson S. The effect of cilia and the mucociliary clearance on successful drug delivery. Biol Pharm Bull. 2015;38:497\u2013506. https:\/\/doi.org\/10.1248\/bpb.b14-00398.","journal-title":"Biol Pharm Bull"},{"key":"1575_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/toxsci\/kfg075","volume":"73","author":"W Hofmann","year":"2003","unstructured":"Hofmann W, Asgharian B. The effect of lung structure on mucociliary clearance and particle retention in human and rat lungs. Toxicol Sci Off J Soc Toxicol. 2003;73:448\u201356. https:\/\/doi.org\/10.1093\/toxsci\/kfg075.","journal-title":"Toxicol Sci Off J Soc Toxicol"},{"key":"1575_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ppul.10079","volume":"33","author":"M Robinson","year":"2002","unstructured":"Robinson M, Bye PTB. Mucociliary clearance in cystic fibrosis. Pediatr Pulmonol. 2002;33:293\u2013306. https:\/\/doi.org\/10.1002\/ppul.10079.","journal-title":"Pediatr Pulmonol"},{"key":"1575_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.resp.2008.03.006","volume":"163","author":"DJ Smith","year":"2008","unstructured":"Smith DJ, Gaffney EA, Blake JR. Modelling mucociliary clearance. Respir Physiol Neurobiol. 2008;163:178\u201388. https:\/\/doi.org\/10.1016\/j.resp.2008.03.006.","journal-title":"Respir Physiol Neurobiol"},{"key":"1575_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1161\/01.cir.60.1.160","volume":"60","author":"MJ Sole","year":"1979","unstructured":"Sole MJ, Drobac M, Schwartz L, et al. The extraction of circulating catecholamines by the lungs in normal man and in patients with pulmonary hypertension. Circulation. 1979;60:160\u20133. https:\/\/doi.org\/10.1161\/01.cir.60.1.160.","journal-title":"Circulation"},{"key":"1575_CR31","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1399-6576.1979.tb01488.x","volume":"23","author":"L Jorfeldt","year":"1979","unstructured":"Jorfeldt L, Lewis DH, L\u00f6fstr\u00f6m JB, Post C. Lung uptake of lidocaine in healthy volunteers. Acta Anaesthesiol Scand. 1979;23:567\u201374. https:\/\/doi.org\/10.1111\/j.1399-6576.1979.tb01488.x.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1575_CR32","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/bcp.12901","volume":"81","author":"JGC van Hasselt","year":"2016","unstructured":"van Hasselt JGC, Rizk ML, Lala M, et al. Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluid. Br J Clin Pharmacol. 2016;81:1113\u201323. https:\/\/doi.org\/10.1111\/bcp.12901.","journal-title":"Br J Clin Pharmacol"},{"key":"1575_CR33","doi-asserted-by":"publisher","DOI":"10.1101\/2024.05.28.596312","author":"Y Guo","year":"2024","unstructured":"Guo Y, Yin J, Aulin LBS, et al. Pharmacodynamic modeling of colistin and imipenem against in vitro Pseudomonas aeruginosa biofilms. BbioRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.05.28.596312.","journal-title":"BbioRxiv"},{"key":"1575_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nmat2347","volume":"8","author":"Y Cu","year":"2009","unstructured":"Cu Y, Saltzman WM. Stealth particles give mucus the slip. Nat Mater. 2009;8:11\u20133. https:\/\/doi.org\/10.1038\/nmat2347.","journal-title":"Nat Mater"},{"key":"1575_CR35","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1128\/AEM.67.7.3299-3303.2001","volume":"67","author":"R Thar","year":"2001","unstructured":"Thar R, Fenchel T. True chemotaxis in oxygen gradients of the sulfur-oxidizing bacterium Thiovulum majus. Appl Environ Microbiol. 2001;67:3299\u2013303. https:\/\/doi.org\/10.1128\/AEM.67.7.3299-3303.2001.","journal-title":"Appl Environ Microbiol"},{"key":"1575_CR36","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/jac\/dkab068","volume":"76","author":"S Frisch","year":"2021","unstructured":"Frisch S, Boese A, Huck B, et al. A pulmonary mucus surrogate for investigating antibiotic permeation and activity against Pseudomonas aeruginosa biofilms. J Antimicrob Chemother. 2021;76:1472\u20139. https:\/\/doi.org\/10.1093\/jac\/dkab068.","journal-title":"J Antimicrob Chemother"},{"key":"1575_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/vaccines9020151","volume":"9","author":"A Mayor","year":"2021","unstructured":"Mayor A, Chesnay A, Desoubeaux G, et al. Therapeutic antibodies for the treatment of respiratory tract infections-current overview and perspectives. Vaccines. 2021;9:151. https:\/\/doi.org\/10.3390\/vaccines9020151.","journal-title":"Vaccines"},{"key":"1575_CR38","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","volume":"76","author":"NRH Stone","year":"2016","unstructured":"Stone NRH, Bicanic T, Salim R, Hope W. Liposomal amphotericin B (AmBisome\u00ae): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions. Drugs. 2016;76:485\u2013500. https:\/\/doi.org\/10.1007\/s40265-016-0538-7.","journal-title":"Drugs"},{"key":"1575_CR39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.2042-7158.1991.tb06647.x","volume":"43","author":"MA Desai","year":"1991","unstructured":"Desai MA, Nicholas CV, Vadgama P. Electrochemical determination of the permeability of porcine mucus to model solute compounds. J Pharm Pharmacol. 1991;43:124\u20137. https:\/\/doi.org\/10.1111\/j.2042-7158.1991.tb06647.x.","journal-title":"J Pharm Pharmacol"},{"key":"1575_CR40","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1039\/AN9911601113","volume":"116","author":"MA Desai","year":"1991","unstructured":"Desai MA, Vadgama P. Estimation of effective diffusion coefficients of model solutes through gastric mucus: assessment of a diffusion chamber technique based on spectrophotometric analysis. Analyst. 1991;116:1113\u20136. https:\/\/doi.org\/10.1039\/AN9911601113.","journal-title":"Analyst"},{"key":"1575_CR41","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1016\/j.biomaterials.2008.12.076","volume":"30","author":"JS Suk","year":"2009","unstructured":"Suk JS, Lai SK, Wang Y-Y, et al. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. Biomaterials. 2009;30:2591\u20137. https:\/\/doi.org\/10.1016\/j.biomaterials.2008.12.076.","journal-title":"Biomaterials"},{"key":"1575_CR42","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/pharmaceutics12020168","volume":"12","author":"M Falavigna","year":"2020","unstructured":"Falavigna M, Stein PC, Flaten GE, di Cagno MP. Impact of mucin on drug diffusion: development of a straightforward in vitro method for the determination of drug diffusivity in the presence of mucin. Pharmaceutics. 2020;12:168. https:\/\/doi.org\/10.3390\/pharmaceutics12020168.","journal-title":"Pharmaceutics"},{"key":"1575_CR43","unstructured":"Villa G. Engineering mucus models: from microstructure to drug diffusion analysis. 2016."},{"key":"1575_CR44","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1103\/PhysRevB.39.1518","volume":"39","author":"G Eng","year":"1989","unstructured":"Eng G. Thin-source concentration-dependent diffusion: a full solution. Phys Rev B. 1989;39:1518\u201329. https:\/\/doi.org\/10.1103\/PhysRevB.39.1518.","journal-title":"Phys Rev B"},{"key":"1575_CR45","volume-title":"The mathematics of diffusion","author":"J Crank","year":"1979","unstructured":"Crank J. The mathematics of diffusion. Oxford University Press; 1979."},{"key":"1575_CR46","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1164\/ajrccm.165.11.165111","volume":"165","author":"JH Widdicombe","year":"2002","unstructured":"Widdicombe JH. Volume of airway surface liquid in health and disease. Am J Respir Crit Care Med. 2002;165:1566\u20131566. https:\/\/doi.org\/10.1164\/ajrccm.165.11.165111.","journal-title":"Am J Respir Crit Care Med"},{"key":"1575_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00181","author":"E Fr\u00f6hlich","year":"2016","unstructured":"Fr\u00f6hlich E, Mercuri A, Wu S, Salar-Behzadi S. Measurements of deposition, lung surface area and lung fluid for simulation of inhaled compounds. Front Pharmacol. 2016. https:\/\/doi.org\/10.3389\/fphar.2016.00181.","journal-title":"Front Pharmacol"},{"key":"1575_CR48","doi-asserted-by":"crossref","unstructured":"Subramanian DA, Kirtane AR, White GN, et al. Identification and Validation of Small Molecules with Mucin-Selective Regiospecific Binding in the Gastrointestinal Tract. 2025. 2025.03.31.646052.","DOI":"10.1101\/2025.03.31.646052"},{"key":"1575_CR49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijpharm.2019.04.032","volume":"564","author":"C Butnarasu","year":"2019","unstructured":"Butnarasu C, Barbero N, Pacheco D, et al. Mucin binding to therapeutic molecules: the case of antimicrobial agents used in cystic fibrosis. Int J Pharm. 2019;564:136\u201344. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.04.032.","journal-title":"Int J Pharm"},{"key":"1575_CR50","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jcis.2016.10.090","volume":"488","author":"VN Boya","year":"2017","unstructured":"Boya VN, Lovett R, Setua S, et al. Probing mucin interaction behavior of magnetic nanoparticles. J Colloid Interface Sci. 2017;488:258\u201368. https:\/\/doi.org\/10.1016\/j.jcis.2016.10.090.","journal-title":"J Colloid Interface Sci"},{"key":"1575_CR51","doi-asserted-by":"publisher","first-page":"12170","DOI":"10.1016\/S0021-9258(20)71335-9","volume":"259","author":"BF Smith","year":"1984","unstructured":"Smith BF, LaMont JT. Hydrophobic binding properties of bovine gallbladder mucin. J Biol Chem. 1984;259:12170\u20137. https:\/\/doi.org\/10.1016\/S0021-9258(20)71335-9.","journal-title":"J Biol Chem"},{"key":"1575_CR52","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s40262-022-01186-3","volume":"61","author":"LBS Aulin","year":"2022","unstructured":"Aulin LBS, Tandar ST, van Zijp T, et al. Physiologically based modelling framework for prediction of pulmonary pharmacokinetics of antimicrobial target site concentrations. Clin Pharmacokinet. 2022;61:1735\u201348. https:\/\/doi.org\/10.1007\/s40262-022-01186-3.","journal-title":"Clin Pharmacokinet"},{"key":"1575_CR53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejpb.2014.12.001","volume":"89","author":"B Patel","year":"2015","unstructured":"Patel B, Gupta N, Ahsan F. Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcome. Eur J Pharm Biopharm. 2015;89:163\u201374. https:\/\/doi.org\/10.1016\/j.ejpb.2014.12.001.","journal-title":"Eur J Pharm Biopharm"},{"key":"1575_CR54","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1021\/acs.molpharmaceut.6b00908","volume":"14","author":"A Ufuk","year":"2017","unstructured":"Ufuk A, Assmus F, Francis L, et al. In vitro and in silico tools to assess extent of cellular uptake and lysosomal sequestration of respiratory drugs in human alveolar macrophages. Mol Pharm. 2017;14:1033\u201346. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00908.","journal-title":"Mol Pharm"},{"key":"1575_CR55","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1128\/AAC.46.2.586-589.2002","volume":"46","author":"GL Drusano","year":"2002","unstructured":"Drusano GL, Preston SL, Gotfried MH, et al. Levofloxacin penetration into epithelial lining fluid as determined by population pharmacokinetic modeling and monte carlo simulation. Antimicrob Agents Chemother. 2002;46:586\u20139. https:\/\/doi.org\/10.1128\/AAC.46.2.586-589.2002.","journal-title":"Antimicrob Agents Chemother"},{"key":"1575_CR56","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01393-23","volume":"68","author":"E Shin","year":"2024","unstructured":"Shin E, Zhang Y, Zhou J, et al. Improved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics. Antimicrob Agents Chemother. 2024;68:e0139323. https:\/\/doi.org\/10.1128\/aac.01393-23.","journal-title":"Antimicrob Agents Chemother"},{"key":"1575_CR57","unstructured":"Uhl PM. Spatiotemporal dynamics of the cystic fibrosis airway microbiome. Ph.D., San Diego State University, 2023."},{"key":"1575_CR58","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.1073\/pnas.0308386101","volume":"101","author":"S Schreiber","year":"2004","unstructured":"Schreiber S, Konradt M, Groll C, et al. The spatial orientation of Helicobacter pylori in the gastric mucus. Proc Natl Acad Sci. 2004;101:5024\u20139. https:\/\/doi.org\/10.1073\/pnas.0308386101.","journal-title":"Proc Natl Acad Sci"},{"key":"1575_CR59","doi-asserted-by":"publisher","first-page":"C2","DOI":"10.1152\/ajpcell.00417.2002","volume":"284","author":"AS Verkman","year":"2003","unstructured":"Verkman AS, Song Y, Thiagarajah JR. Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease. Am J Physiol Cell Physiol. 2003;284:C2-15. https:\/\/doi.org\/10.1152\/ajpcell.00417.2002.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1575_CR60","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1148\/rg.285075212","volume":"28","author":"S Martinez","year":"2008","unstructured":"Martinez S, Heyneman LE, McAdams HP, et al. Mucoid impactions: finger-in-glove sign and other CT and radiographic features. Radiographics. 2008;28:1369\u201382. https:\/\/doi.org\/10.1148\/rg.285075212.","journal-title":"Radiographics"},{"key":"1575_CR61","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-bioeng-062117-121156","volume":"20","author":"TL Carlson","year":"2018","unstructured":"Carlson TL, Lock JY, Carrier RL. Engineering the mucus barrier. Annu Rev Biomed Eng. 2018;20:197\u2013220. https:\/\/doi.org\/10.1146\/annurev-bioeng-062117-121156.","journal-title":"Annu Rev Biomed Eng"},{"key":"1575_CR62","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1128\/IAI.71.10.5565-5575.2003","volume":"71","author":"LP Aristoteli","year":"2003","unstructured":"Aristoteli LP, Willcox MDP. Mucin degradation mechanisms by distinct Pseudomonas aeruginosa isolates in vitro. Infect Immun. 2003;71:5565\u201375. https:\/\/doi.org\/10.1128\/IAI.71.10.5565-5575.2003.","journal-title":"Infect Immun"},{"key":"1575_CR63","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.addr.2008.09.011","volume":"61","author":"N Sanders","year":"2009","unstructured":"Sanders N, Rudolph C, Braeckmans K, et al. Extracellular barriers in respiratory gene therapy. Adv Drug Deliv Rev. 2009;61:115\u201327. https:\/\/doi.org\/10.1016\/j.addr.2008.09.011.","journal-title":"Adv Drug Deliv Rev"},{"key":"1575_CR64","doi-asserted-by":"publisher","first-page":"7273","DOI":"10.1128\/AAC.03132-14","volume":"58","author":"N Doroshenko","year":"2014","unstructured":"Doroshenko N, Tseng BS, Howlin RP, et al. Extracellular DNA impedes the transport of Vancomycin in Staphylococcus epidermidis biofilms preexposed to subinhibitory concentrations of Vancomycin. Antimicrob Agents Chemother. 2014;58:7273\u201382. https:\/\/doi.org\/10.1128\/AAC.03132-14.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01575-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-025-01575-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01575-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T10:32:40Z","timestamp":1766053960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-025-01575-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":64,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1575"],"URL":"https:\/\/doi.org\/10.1007\/s40262-025-01575-4","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yuchen Guo, Jinqiu Yin, Sirin Yonucu, Catherijne A.J. Knibbe, Tingjie Guo and Coen van Hasselt declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript. Catherijne A. J. Knibbe is an Editorial Board member of Clinical Pharmacokinetics. Catherijne A. J. Knibbe was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Data sharing is not applicable to this article as no datasets are associated with this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The code used in this study is available via the GitHub repository\n                      \n                      .","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Conceptualization: J.G. Coen van Hasselt, Jinqiu Yin, Tingjie Guo; Methodology: Yuchen Guo, Tingjie Guo, Sirin Yonucu; Formal analysis and investigation: Yuchen Guo, Tingjie Guo; Writing \u2013 original draft preparation: Yuchen Guo; Writing \u2013 review and editing: Yuchen Guo, Catherijne A.J. Knibbe, Tingjie Guo, J.G. Coen van Hasselt; Funding acquisition: J.G. Coen van Hasselt; Supervision: J.G. Coen van Hasselt, Tingjie Guo.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}